🎉 Up to 70% Off Selected ItemsShop Sale
Xarelto 20Mg Fc 28 Tablets
An oral anticoagulant medicine to reduce the risk of harmful blood clot formation. It works by helping maintain normal blood flow and reducing clot-related complications.
Indications:
- Prevention of stroke in adults with non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis and pulmonary embolism.
- Prevention of recurrent deep vein thrombosis and pulmonary embolism after initial treatment.
Main Active Ingredient:
- Rivaroxaban.
Precautions:
- Do not use in case of known hypersensitivity to rivaroxaban or any of the excipients.
- Use with caution in patients with renal impairment, hepatic disease, or increased risk of bleeding.
- Consult a physician before use during pregnancy or breastfeeding.
- Keep out of reach of children.
Side Effects:
- Bleeding events such as gastrointestinal or nasal bleeding.
- Anemia, dizziness, or headache.
- Gastrointestinal disturbances such as nausea or abdominal pain.
Drug–Drug Interactions:
- Anticoagulants such as warfarin, heparin, dabigatran, apixaban, and edoxaban, which may significantly increase the risk of bleeding.
- Antiplatelet agents such as aspirin and clopidogrel may increase bleeding risk.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, which may increase the risk of gastrointestinal bleeding.
- Strong CYP3A4 and P-glycoprotein inducers such as rifampicin, carbamazepine, phenytoin, phenobarbital, and St. John’s Wort, which may reduce rivaroxaban effectiveness.
- Consult a healthcare professional before combining with other treatments.
Indications:
- Prevention of stroke in adults with non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis and pulmonary embolism.
- Prevention of recurrent deep vein thrombosis and pulmonary embolism after initial treatment.
Main Active Ingredient:
- Rivaroxaban.
Precautions:
- Do not use in case of known hypersensitivity to rivaroxaban or any of the excipients.
- Use with caution in patients with renal impairment, hepatic disease, or increased risk of bleeding.
- Consult a physician before use during pregnancy or breastfeeding.
- Keep out of reach of children.
Side Effects:
- Bleeding events such as gastrointestinal or nasal bleeding.
- Anemia, dizziness, or headache.
- Gastrointestinal disturbances such as nausea or abdominal pain.
Drug–Drug Interactions:
- Anticoagulants such as warfarin, heparin, dabigatran, apixaban, and edoxaban, which may significantly increase the risk of bleeding.
- Antiplatelet agents such as aspirin and clopidogrel may increase bleeding risk.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, which may increase the risk of gastrointestinal bleeding.
- Strong CYP3A4 and P-glycoprotein inducers such as rifampicin, carbamazepine, phenytoin, phenobarbital, and St. John’s Wort, which may reduce rivaroxaban effectiveness.
- Consult a healthcare professional before combining with other treatments.
$8.45
Original: $24.15
-65%Xarelto 20Mg Fc 28 Tablets—
$24.15
$8.45Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
An oral anticoagulant medicine to reduce the risk of harmful blood clot formation. It works by helping maintain normal blood flow and reducing clot-related complications.
Indications:
- Prevention of stroke in adults with non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis and pulmonary embolism.
- Prevention of recurrent deep vein thrombosis and pulmonary embolism after initial treatment.
Main Active Ingredient:
- Rivaroxaban.
Precautions:
- Do not use in case of known hypersensitivity to rivaroxaban or any of the excipients.
- Use with caution in patients with renal impairment, hepatic disease, or increased risk of bleeding.
- Consult a physician before use during pregnancy or breastfeeding.
- Keep out of reach of children.
Side Effects:
- Bleeding events such as gastrointestinal or nasal bleeding.
- Anemia, dizziness, or headache.
- Gastrointestinal disturbances such as nausea or abdominal pain.
Drug–Drug Interactions:
- Anticoagulants such as warfarin, heparin, dabigatran, apixaban, and edoxaban, which may significantly increase the risk of bleeding.
- Antiplatelet agents such as aspirin and clopidogrel may increase bleeding risk.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, which may increase the risk of gastrointestinal bleeding.
- Strong CYP3A4 and P-glycoprotein inducers such as rifampicin, carbamazepine, phenytoin, phenobarbital, and St. John’s Wort, which may reduce rivaroxaban effectiveness.
- Consult a healthcare professional before combining with other treatments.
Indications:
- Prevention of stroke in adults with non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis and pulmonary embolism.
- Prevention of recurrent deep vein thrombosis and pulmonary embolism after initial treatment.
Main Active Ingredient:
- Rivaroxaban.
Precautions:
- Do not use in case of known hypersensitivity to rivaroxaban or any of the excipients.
- Use with caution in patients with renal impairment, hepatic disease, or increased risk of bleeding.
- Consult a physician before use during pregnancy or breastfeeding.
- Keep out of reach of children.
Side Effects:
- Bleeding events such as gastrointestinal or nasal bleeding.
- Anemia, dizziness, or headache.
- Gastrointestinal disturbances such as nausea or abdominal pain.
Drug–Drug Interactions:
- Anticoagulants such as warfarin, heparin, dabigatran, apixaban, and edoxaban, which may significantly increase the risk of bleeding.
- Antiplatelet agents such as aspirin and clopidogrel may increase bleeding risk.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, which may increase the risk of gastrointestinal bleeding.
- Strong CYP3A4 and P-glycoprotein inducers such as rifampicin, carbamazepine, phenytoin, phenobarbital, and St. John’s Wort, which may reduce rivaroxaban effectiveness.
- Consult a healthcare professional before combining with other treatments.
